Cheng Jing
Cheng Jing, wani masanin kimiyya wanda tawagarsa ta ƙirƙiro "ƙwayar halittar DNA" ta farko ta China don gano cutar SARS shekaru 17 da suka gabata, yana ba da gudummawa sosai ga yaƙin da ake yi da annobar COVID-19.
Cikin ƙasa da mako guda, ya jagoranci wata ƙungiya don ƙirƙirar kayan aiki wanda zai iya gano ƙwayoyin cuta guda shida na numfashi a lokaci guda, ciki har da COVID-19, da kuma biyan buƙatun gaggawa na ganewar asibiti.
An haifi Cheng a shekarar 1963, shugaban kamfanin kimiyyar halittu na gwamnati CapitalBio Corp, mataimakin majalisar wakilan jama'a ta kasa ne kuma masanin kimiyya na Kwalejin Injiniya ta kasar Sin.
A ranar 31 ga Janairu, Cheng ya sami kira daga Zhong Nanshan, wani fitaccen kwararre kan cututtukan numfashi, game da sabbin kamuwa da cutar huhu ta coronavirus, a cewar wani rahoto da Science and Technology Daily ta fitar.
Zhong ya gaya masa game da matsalolin da ake fuskanta a asibitoci game da gwajin sinadarin nucleic acid.
Alamomin COVID-19 da mura iri ɗaya ne, wanda hakan ya sa gwajin da ya dace ya fi muhimmanci.
Gano cutar cikin sauri domin killace marasa lafiya don ƙarin magani da kuma rage kamuwa da cuta yana da matuƙar muhimmanci wajen shawo kan barkewar cutar.
A zahiri, Cheng ya riga ya kafa wata ƙungiya don yin bincike kan gwajin cutar coronavirus kafin ya sami kira daga Zhong.
Tun farko, Cheng ya jagoranci tawagar Jami'ar Tsinghua da kamfanin don su zauna a dakin gwaje-gwaje dare da rana, suna amfani da dukkan minti don ƙirƙirar sabuwar na'urar gwaji ta DNA.
Cheng yakan ci taliyar taliya nan take a lokacin. Yakan zo da kayansa kowace rana domin ya shirya zuwa "yaƙi" a wasu birane.
"Ya ɗauki makonni biyu kafin mu samar da ƙwayoyin halittar DNA don SARS a shekarar 2003. A wannan karon, mun yi ƙasa da mako guda," in ji Cheng.
"Ba tare da wadatar gogewa da muka tara a shekarun baya ba da kuma ci gaba da goyon bayan da kasar ke bayarwa ga wannan fanni, da ba za mu iya kammala aikin cikin sauri haka ba."
Kwamfutar da aka yi amfani da ita wajen gwajin cutar SARS ta ɗauki awanni shida kafin a samu sakamako. Yanzu, sabon kwamfutar kamfanin zai iya gwada ƙwayoyin cuta 19 na numfashi a lokaci guda cikin awanni ɗaya da rabi.
Duk da cewa ƙungiyar ta rage lokacin bincike da haɓaka guntu da na'urar gwaji, tsarin amincewa bai yi sauƙi ba kuma daidaiton bai ragu kwata-kwata ba.
Cheng ya tuntubi asibitoci huɗu don gwaje-gwajen asibiti, yayin da matsayin masana'antar shine uku.
"Mun fi kwanciyar hankali fiye da lokacin da muka gabata, muna fuskantar annobar," in ji Cheng. "Idan aka kwatanta da 2003, ingancin bincikenmu, ingancin samfura da ƙarfin masana'antu duk sun inganta sosai."
A ranar 22 ga Fabrairu, kayan aikin da ƙungiyar ta ƙirƙiro sun sami amincewar Hukumar Kayayyakin Lafiya ta Ƙasa kuma an yi amfani da su cikin sauri a layin gaba.
A ranar 2 ga Maris, Shugaba Xi Jinping ya ziyarci Beijing don shawo kan annobar da kuma rigakafinta a kimiyya. Cheng ya bayar da rahoto na mintuna 20 kan amfani da sabuwar fasahar wajen rigakafin annobar da kuma nasarorin bincike na kayan aikin gano cutar.
An kafa kamfanin CapitalBio Technology, babban reshen CapitalBio Corp, a shekarar 2000, kuma yana yankin ci gaban tattalin arziki da fasaha na Beijing, ko kuma Beijing E-Town.
Kimanin kamfanoni 30 a yankin sun shiga kai tsaye a yakin da ake yi da annobar ta hanyar haɓaka da ƙera wurare kamar na'urorin numfashi, na'urorin tattara jini, na'urorin tsarkake jini, na'urorin ɗaukar hoton CT da magunguna.
A lokacin zaman tattaunawa biyu na wannan shekarar, Cheng ya ba da shawarar cewa ƙasar ta hanzarta kafa cibiyar sadarwa mai wayo kan manyan cututtukan da ke tasowa, waɗanda za su iya isar da bayanai game da annobar da marasa lafiya ga hukumomi cikin sauri.
Lokacin Saƙo: Yuni-12-2020
